Stockhouse on MSN5 天
Voyageur Pharmaceuticals With CEO, Brent Willis | February 19th, 2025
The Market Online speaks with Voyageur Pharmaceuticals CEO, Brent Willis as Voyageur Advances MRI Drug Development Using Next ...
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes
Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the launch of ...